davidbrennan

324 POSTS 0 COMMENTS

Six-month LOCOMOTIVE Registry outcomes presented

At the 2017 Charing Cross Symposium (25–28 April, London, UK) Klaus Amendt presented six-month outcomes from the all-comers LOCOMOTIVE Registry, which is investigating the...

The search for modifiable risk factors to improve bypass results is...

A large study of the outcomes of 3,033 patients undergoing lower extremity bypass has reported a 10.6% infection rate and identified procedural risk factors....

Lutonix for dysfunctional arteriovenous fistulae shows improved primary patency vs. plain...

Interim twelve-month data from the Lutonix AV Clinical Trial indicate that treatment of dysfunctional arteriovenous (AV) fistulae with Bard’s Lutonix drug-coated balloon (DCB) produces...

Alucent Medical receives FDA approval to begin Natural Vascular Scaffolding clinical...

Alucent Medical has announced that it has received US Food and Drug Administration (FDA) approval to begin Phase 1 human clinical studies of Natural Vascular...

Endologix provides update on the Nellix sealing system US regulatory status

Endologix has met with the US Food and Drug Administration (FDA) regarding its Nellix endovascular aneurysm sealing system (EVAS System). Based upon that meeting and...

First patient enrolled and treated in the Altura stent graft ALTITUDE...

Lombard Medical has now enrolled and treated the first patient in its global registry to evaluate its Altura endograft system. The ALTITUDE registry (Altura impact on the treatment of abdominal...

QT Vascular enters into asset purchase option agreement with Medtronic

QT Vascular has entered into an asset purchase option agreement with Medtronic for the acquisition of the group's non-drug coated Chocolate percutaneous transluminal angioplasty...

Medeon Biodesign gets approval for CE mark study for the XPro...

Medeon Biodesign has received approval by the New Zealand Health and Disability Ethics Committees, Ministry of Health to commence the CE clinical trial for...

Lombard Medical’s endovascular product portfolio presented at 2017 Charing Cross Symposium

Lombard Medical’s portfolio of endovascular stent graft systems, Altura and Aorfix, were featured in scientific presentations at the 39th annual Charing Cross International Symposium (CX;...

Clearing the clot: New horizons in deep vein thrombosis treatment

In this supplement: --Life post-ATTRACT: The new challenge of DVT treatment --The future of DVT intervention in Europe: what needs to happen next --"With...

Mayo Clinic researchers report encouraging fenestrated and branched EVAR outcomes

Significant success has been achieved in treating complex proximal aneurysms using a combination of fenestrated and branched graft devices, based on a report of...

Intact Vascular appoints Howard Rosen as vice president of marketing and...

Howard Rosen has joined Intact Vascular’s executive management team as vice president of marketing and business development. In this position, Rosen will lead the...

Contego Medical receives CE mark for Vanguard IEP peripheral balloon angioplasty...

Contego Medical has announced that it has received CE mark for its Vanguard IEP peripheral balloon angioplasty system with integrated embolic protection. The company...

CX audience homes in on grey area between drug-coated balloons and...

At the 2017 Charing Cross Symposium (CX; 25–28 April, London, UK), delegates heard brand new data for drug-coated balloons (DCBs) in “wider use” scenarios...

Watch and learn: CX Aortic Edited Cases

Tuesday’s CX Aortic Edited Cases session featured exciting and engaging standing-room only case presentations, including Andrew Holden’s (Auckland, New Zealand) first-in-man implantation of the...

Remembering that “babies are not little adults” at CX Paediatric Vascular...

The particular complexities of dealing with paediatric vessels were discussed in depth at Tuesday’s varied and informative CX Paediatric Vascular Emergencies and Case Presentations...

Approaching vascular malformations

In Tuesday’s CX Congenital Vascular Malformations session, delegates heard about how approaching congenital vascular malformations with systematic pathways of care and classification systems can...

Getinge becomes a single brand company and launches Advanta V12 32mm...

Getinge has announced that, in order to better convey its customer offering and strengthen its position, it has grouped its portfolio under one single...

Lombard Medical appoints new CEO

Kurt Lemvigh has been appointed as its new chief executive officer of Lombard Medical, effective immediately. Lemvigh is a veteran medical device executive with over...

Lombard Medical CEO steps down

Simon Hubbert has stepped down from his position as chief executive officer on 18 April after serving in the role for more than six years. A...

Ra Medical Systems launches catheters and lasers in Northern Europe

Ra Medical Systems and bo medical technologies, have announced the launch of the Dabra atherectomy system for cardiovascular and Pharos excimer laser for dermatology...

QXMédical announces sponsorship of leading EVAR planning website

QXMédical has announced its sponsorship of EVARplanning.com, an online tool which helps vascular and cardiovascular specialists plan complex endovascular aneurysm repair (EVAR) procedures. Developed by...

Essential Medical addressing the growing large bore vascular closure market

Essential Medical has announced the publication of the MANTA CE marking study results in JACC Interventions titled: “Percutaneous plug-based arteriotomy closure device for large-bore...

Lombard Medical and MicroPort Scientific Corporation finalise strategic partnership agreements

Lombard Medical and MicroPort Scientific Corporation have finalised the definitive agreements to their strategic partnership first announced on 19 December 2016. The partnership will allow Lombard to accelerate...

Capturer 7F thrombus extraction catheter receives CE mark

iVascular has obtained CE mark for the thrombus extraction catheter Capturer 7F. A company press release states that Capturer 7F has “outstanding extraction capacity” and “the...

Endologix announces enrolment of first patients in ELEVATE IDE clinical study

Endologix has announced today that the first patients were treated in the ELEVATE (Expanding patient applicability with polymer sealing Ovation Alto stent graft) investigational...

Vascular News Charing Cross US Edition 2017

Highlights: -Achieving consensus via Pathways of Care -CX Venous Workshop -CX Vascular Access course -CX Peripheral and Aortic Edited Live Cases -CX ilegx Collaboration Day...

Vascular News Charing Cross Edition 2017

Highlights: -Achieving consensus via Pathways of Care -CX Venous Workshop -CX Vascular Access course -CX Peripheral and Aortic Edited Live Cases -CX ilegx Collaboration Day...

Mounting evidence supports increasing use of parallel graft endovascular techniques for...

In a 15-year evolution, parallel graft techniques have emerged as part of the effort to rescue or preserve excluded aortic branches in the context...

Leaving nothing behind: Is it time to move away from primary...

In this supplement: -Femoropopliteal disease: The rationale of leaving nothing behind -Treatment algorithm: How DCB evidence changed my practice -From stents to drug-coated balloons:...

Intact Vascular completes enrolment in TOBA II clinical trial

Intact Vascular’s TOBA II (Tack optimized balloon angioplasty II) clinical trial has completed enrolment. A total of 210 patients have been enrolled in TOBA II at 33 sites...

Next-generation stent systems for lower extremity arterial occlusive lesions

Balloon angioplasty has been utilised in lower extremity revascularisation procedures since the 1970s, but the durability of this technique is limited by both mechanical...

Preclinical diagnosis of abdominal aortic aneurysm

The prevalence of abdominal aortic aneurysms in patients over 55 vary between 4% and 7.2%, depending on age, gender and geographic location. The innovative...

The evolution of the aortic neck after EVAR

Continuous aortic enlargement at the level of infrarenal aortic neck has been reported after endovascular repair (EVAR) of abdominal aortic aneurysm. Current concepts regarding...

New guidelines aim “to harmonise descending thoracic aorta management” in Europe...

Updated European Society for Vascular Surgery (ESVS) clinical practice guidelines regarding the management of diseases of the descending thoracic aorta have been published in...

Indigenous South American group exhibit healthiest arteries of any population ever...

The Tsimane people—a forager-horticulturalist population of the Bolivian Amazon—have the lowest reported levels of vascular aging for any population, with coronary atherosclerosis five times...

RaySafe unveils new real-time dosimeter

Unfors RaySafe has introduced the RaySafe i3, to its suite of real-time dosimetry products, at the European Society of Radiology in Vienna.   The RaySafe Real-Time...

Corindus Vascular Robotics announces closing of private placement for US$45m

Corindus Vascular Robotics has announced the closing of its previously announced private placement pursuant to which it issued and sold an aggregate of 68,055,700...

ISVS 2017 annual meeting to consider “global perspectives and international standards...

The 2017 International Society for Vascular Surgery (ISVS) annual meeting will be held in Sibiu, Romania from 19–22 July. Vascular News spoke with Sherif...

Smartphone over treadmill: Mapping claudication with Google Maps

The use of GPS mapping tools has become a cornerstone of modern life. A study published by the Journal of Vascular Surgery has demonstrated...

Women face higher mortality following TEVAR for intact descending thoracic aortic...

Even after adjusting for differences in age and comorbidities, female patients have higher perioperative mortality and lower long-term survival after thoracic endovascular aneurysm repair...

Teleflex announces 510(k) clearance and US launch of Spectre guidewire

Teleflex has announced 510(k) clearance by the Food and Drug Administration and US commercial launch of the Spectre guidewire. The Spectre guidewire is engineered with...

Nobilis Health acquires Hamilton Vein Center

Nobilis Health has closed its previously announced acquisition of Hamilton Vein Center. “Hamilton Vein Center not only increases our in-network patient volume mix to over...

PQ Bypass announces CE mark for Detour percutaneous bypass technologies

PQ Bypass has announced CE mark approval for a trio of proprietary devices: the Torus stent graft system, PQ Snare, and PQ Crossing Device,...

Eyes may hold clues to future narrowing of leg vessels

Changes in tiny blood vessels of the eye may predict a higher risk of later narrowing in the large blood vessels in the legs,...

Lutonix AV results provide tailwind for drug-coated balloons in dysfunctional arteriovenous...

Scott Trerotola presented the first release of eight-month data from the Lutonix AV trial at the Leipzig Interventional Course (LINC; 24–27 January, Leipzig, Germany)...

Tigris stent gets Health Canada approval for peripheral artery disease

Gore has announced the Health Canada approval of the Tigris vascular stent, a dual-component stent with a unique fluoropolymer/nitinol design. The device, which gained...

Bluegrass Vascular announces strategic relationship with Merit Medical

Bluegrass Vascular Technologies is entering into a strategic relationship with Merit Medical Systems. The agreement will streamline European distribution of the recently CE mark-approved Surfacer Inside-Out...

CMS close to reimbursing supervised exercise therapy to treat PAD in...

The US Centers for Medicare & Medicaid Services (CMS) have released the proposed decision memo for the approval of supervised exercise therapy for the...

Global cohorts report drug-coated balloon success above the knee and “promising”...

Three global registries reported fresh data at the 2017 Leipzig Interventional Course (LINC; 24–27 January, Leipzig, Germany), all of which showed encouraging outcomes for...

Percutaneous bypass using femoral vein could be “an important step” in...

In a first-time data release, Dierk Scheinert presented six-month outcomes from the DETOUR trial of percutaneous bypass in long segment femoropopliteal occlusions at the...

DANCE trial shows positive results for micro-infusion device with dexamethasone

Mahmood Razavi and George Adams, the national co-principal investigators of Mercator MedSystem’s DANCE trial, have each presented comprehensive 13-month data from the trial during...

Promising 12- and 24-month East Asian experiences for drug-coated balloons

Results from two Asian studies presented at LINC 2017 (24–27 January, Leipzig, Germany), show encouraging outcomes for drug-coated balloon versus percutaneous transluminal angioplasty treatment...

CONSEQUENT trial 12-month data support drug-coated balloons for long lesions

Twelve-month results of the CONSEQUENT trial have shown lower late lumen loss, lower rates of 12-month target lesion revascularisation and longer walking distance increases...

Alvimedica announces completion of enrolment in Ilumina study

Alvimedica’s Illumina study enrolment is now complete. The Illumina study has been designed to evaluate the efficacy and safety of the new NiTiDES self-expanding...

Registration opens for the 2017 Vascular Annual Meeting

Registration is now open for the 2017 Vascular Annual Meeting, scheduled for 31 May–3 June in San Diego, USA. Plenaries and exhibits open on...

Endovascular treatment in the aortic arch

The development of endovascular stent grafts in the descending aorta has significantly reduced the number of open surgical repairs being performed. However, the ascending...

BTG receives FDA 510(k) clearance for EKOS Control Unit 4.0

BTG has announced US Food and Drug Administration (FDA) 510(k) clearance has been granted to the EKOS Control Unit 4.0. The EKOS system includes an ultrasonic...

Cagent Vascular announces FDA 510(k) clearance of Serranator Alto serration balloon...

Cagent Vascular has announced US Food and Drug Administration 510(k) clearance of its lead product, the Serranator Alto percutaneous transluminal angioplasty serration balloon catheter. The Serranator...

From frontline to ward: Lessons in trauma from the “War on...

Conflict has forever been a catalyst for medical advances. In the 20th century, for example, two World Wars and innumerable smaller civil and interstate...

Obituary: Edward B Diethrich

Edward B Diethrich, an internationally esteemed cardiovascular surgeon, inventor, and philanthropist, succumbed to complications of a brain tumour on 23 February at the age...

Responding to terror: Damage control strategies during the 2015 Paris attacks

On the night of 13 November 2015, bombing and shooting attacks in Paris, France, killed 130 people and wounded another 352. The attacks—targeting a...

Last patient enrolled in SB-030 SHIELD trial for peripheral artery disease...

Symic Bio, has completed enrolment for the SHIELD clinical trial of SB-030 in peripheral artery disease. The trial will evaluate the safety and efficacy...

Cook launches 140mm Zilver PTX drug-eluting stent

Cook has extended its Zilver PTX product portfolio with a 140mm drug-eluting stent. Physicians will now be able to treat longer lesions with just...

Midterm FEVAR physician-sponsored IDE data “excellent”

Benjamin W Starnes, chief of Vascular Surgery at the University of Washington, USA, and one of the world’s foremost authorities on the treatment of...

VeClose trial reports “excellent” clinical and quality of life outcomes at...

The pivotal VeClose trial is investigating the performance of the VenaSeal cyanoacrylate-based adhesive (Medtronic) for vein closure. At LINC 2017, Vascular News caught up...

Long-term heavy drinking may age arteries over time

Heavy alcohol drinking habits over the years may prematurely age arteries, especially in men, putting them at an increased risk for heart disease, according...

Using the Tack endovascular system to treat vessel dissection

At LINC 2017 Vascular News spoke to Peter Schneider (Kaiser Foundation Hospital, Honolulu, Hawaii, USA) about the Tack endovascular system (Intact Vascular), an implant designed to repair...

Carbon-coated stents in patients with atherosclerotic iliac artery lesions

By Nicola Troisi, Department of Surgery, Vascular and Endovascular Surgery Unit, San Giovanni di Dio Hospital, Florence, Italy Endovascular treatment is now the preferred treatment...

Promising results with novel external pneumatic device for fistula maturation

Renal failure affects millions of patients worldwide, with many renal failure patients progressing to end-stage renal disease, requiring dialysis treatment. Dialysis options include central...

The duplex criteria for paediatric reflux testing

Primary chronic venous disease is poorly documented in paediatric patients, excluding those diagnosed with Klippel-Trenaunay syndrome (KTS) and post-thrombotic syndrome, writes Dawn Coleman. The...

FlowAid receives FDA US market clearance for the FA100 SCCD

Having received CE mark approval in July and Health Canada approval in August of last year, FlowAid Medical Technologies has now received US Food and Drug Administration (FDA)...

Laminate Medical Technologies completes US$8m Series B financing round

Laminate Medical Technologies has announced the close of a US$8m Series B financing round. This round of funding will help finance continued development and...

Endologix completes enrolment in Ovation Lucy study

Endologix has completed patient enrolment in the Lucy (Evaluation of females who are underrepresented candidates for abdominal aortic aneurysm repair) study, a multicentre post-market...

Mechanical approaches to improving AV fistula outcomes

Although arteriovenous (AV) fistulae are considered the gold standard for vascular access for haemodialysis and have a low rate of complications and improved longevity...

Tunneled cuffed dialysis catheters: Why does the catheter’s tip matter?

A tunneled catheter remains the most common access in patients initiating haemodialysis.1 This is most likely because the catheters are ready to use immediately...

Micro Medical Solutions receives CE mark for MicroStent

Micro Medical Solutions (MMS) has received CE mark approval for MicroStent, allowing the company to market this technology in Europe. MicroStent is a vascular...

TOBA II BTK clinical trial commences enrolment with first implant of...

Intact Vascular’s TOBA II BTK (Tack optimised balloon angioplasty II below the knee) clinical trial has commenced enrolment, with the first patient treated by Joseph Cardenas at Yuma Regional Hospital and...

Endovenous laser therapy of saphenous vein reflux using thulium laser with...

In this clinical study the one-year results of the endovenous laser therapy (ELT) application of 1,940nm laser (Vela XL, Boston Scientific) with respect to...

Medtronic announces Health Canada licence for IN.PACT Admiral drug-coated balloon

Medtronic Canada, a subsidiary of Medtronic, has announced it has obtained Health Canada licence for the IN.PACT Admiral drug-coated balloon. IN.PACT Admiral is a primary...

Flow Forward reports Arteriovenous Fistula Eligibility system data

Flow Forward Medical has announced the completion of a preclinical study and a computational fluid dynamics study supporting continued development of the company's Arteriovenous...

SUPERSUB trial update and precise stent placement with the Presto technique

At LINC 2017 (24–27 January, Leipzig, Germany), Luis Mariano Palena (Policlinico Abano Terme, Abano Terme, Italy) presented an update on the SUPERSUB trial, which...

Intravascular ultrasound in venous disease

The question is often asked: is intravascular ultrasound (IVUS) necessary in a deep venous practice? Stephen Black writes that it was certainly a question that...

First implant of Viabahn VBX stent graft completed

Houston Methodist Hospital has become the first US institution to implant the newly FDA-approved Viabahn VBX balloon expandable endoprosthesis (VBX stent graft; Gore), to...

Japanese IN.PACT SFA study demonstrates clinical outcomes consistent with other trials

The one-year clinical outcomes from the MDT-2113 IN.PACT SFA Japan trial have been released. The data was recently presented by Osamu Iida, Kansai Rosai...

BEST-CLI trial enrolment nears halfway mark

As the second year of enrolment draws to a close, the Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI)...

The success of deep venous intervention rests on mid- to long-term...

In this interview, Vascular News speaks to Prakash Saha, King’s College Hospital, London, UK, about the growth of deep venous treatment and how the...

LUMINOR Registry may help “reopen the door” for drug-coated balloons below...

The LUMINOR Registry is a real-world prospective multicentre study evaluating iVascular’s Luminor paclitaxel-eluting balloon for treating advanced limb ischaemia. Vascular News spoke to Vincent...

Achieving haemostasis in radial artery access

The VasoStat (Forge Medical) is a haemostasis device designed for radial, brachial and transpedal procedures. The device is placed over the puncture site to...

Global variations in abdominal aortic aneurysm care revealed

Despite homogenous professional society recommendations, significant global variation still exists in the management of abdominal aortic aneurysms, a US study published in Circulation has...

R Clement Darling III

Although he resolved to avoid a career in medicine as a young man, R Clement Darling III eventually “fell into” the field of vascular...

Promising early results for Lutonix US IDE trial in obstructed AV...

The first US randomised controlled trial for drug-coated balloon use for arteriovenous fistula obstructions for 50 years, the Lutonix (Bard) IDE trial was a...

Animal experiments raise possibility of wireless vascular flow monitoring

Remote monitoring of bypass flow using an implantable piezoelectric sensor, which can also be placed on stents, has shown successful and reliable transmission of...

Combined 12-month analysis of ILLUMENATE EU and US trials presented at...

At LINC 2017 (24–27 January, Leipzig, Germany), Sean Lyden (Cleveland Clinic, Cleveland, USA) presented an update on the 12-month results of the European and...

Automated planning software could lead to wider FEVAR adoption

While the long-term durability of fenestrated endovascular repair (FEVAR) has been established, the need for accurate procedural planning may act as a barrier to...

Mind over matter: EVAR under hypnosis

The use of hypnosis during endovascular aneurysm repair (EVAR) may improve haemodynamic and respiratory stability and allow faster patient recovery, according to a presentation...

VeClose trial indicates 24-month non-inferiority of VenaSeal versus radiofrequency ablation

Two-year outcomes of the VeClose pivotal trial have been reported, showing a 94.3% closure rate and “continued non-inferiority results to radiofrequency ablation” when using...

MOCA effective for greater saphenous vein insufficiency out to three years

A Dutch study of greater saphenous vein insufficiency patients has found that mechanochemical ablation (MOCA; ClariVein, Vascular Insights) is an effective and safe treatment...

Cyanoacrylate adhesive perforator embolisation successful while avoiding risk of “inadvertent thermal...

Fresh data from a Turkish CAPE (cyanoacrylate adhesive perforator embolisation) trial indicate that the method is “as effective as endovenous thermoablative techniques, without the...

A New DCB Era of Safety and Efficacy

In this supplement: -SAFEPAX: No drug coating pitfalls -Why the RAPID trial is of clinical importance for a paradigm shift -Vascular access rescue with...

Endologix resumes shipments of all sizes of AFX2 systems

Endologix has resumed shipments of all sizes of AFX2 endovascular abdominal aortic aneurysm systems. The large diameter sizes of AFX2 were placed on a temporary...

Tack endovascular system secures CE mark for repair of dissections following...

Intact Vascular has attained the CE mark for the Tack endovascular system for the repair of arterial dissections following percutaneous transluminal angioplasty (PTA) below...

ESVS publishes new descending thoracic aortic disease guidelines

Updated European Society for Vascular Surgery (ESVS) clinical practice guidelines regarding the management of diseases of the descending thoracic aorta have been published in...

“Non-fluoroscopic imaging and navigation will replace our current modalities for endovascular...

Due to its two-dimensional (2D) nature and the high radiation exposure associated with its use, fluoroscopy is an imperfect solution to endovascular surgery’s need...

Vascular News 73 – January 2017 US Edition

Highlights: -Animal experiments raise possibility of wireless vascular flow monitoring -Global variations in abdominal aortic aneurysm care revealed -Jerry Fortuna: Battlefield trauma -Stephen Black:...

Vascular News 73 – January 2017

Highlights: -Animal experiments raise possibility of wireless vascular flow monitoring -Global variations in abdominal aortic aneurysm care revealed -Jerry Fortuna: Battlefield trauma -Stephen Black:...

Lombard Medical gets Japanese approval for IntelliFlex LP delivery system

Lombard Medical has announced approval from the Japanese Ministry of Health, Labour and Welfare for its IntelliFlex low-profile (LP) delivery system for the Aorfix...

Intact Vascular closes on additional funding to advance development of Tack...

Current Intact Vascular investors—New Enterprise Associates, Quaker Partners and HIG BioHealth Partners—have exercised their right to invest additional capital as part of the company’s...

Abbott completes the acquisition of St Jude Medical

Abbott has now completed the acquisition of St Jude Medical. The Abbott press release announcing the completion of the acquisition said, “The transaction provides...

Mind over matter: EVAR under hypnosis

The use of hypnosis during endovascular aneurysm repair (EVAR) may improve haemodynamic and respiratory stability and allow faster patient recovery, according to a presentation...

Comparison of EVAR 1 and ENGAGE data shows the evolution of...

The EVAR 1 trial—investigating the efficacy of endovascular aneurysm repair (EVAR) versus open repair—and the ENGAGE registry—examining the performance of the Endurant (Medtronic) stent...

Abbott acquisition of St Jude Medical set to close on 4...

Abbott has announced its intention to close the acquisition of St Jude Medical on Wednesday, 4 January 2017. The announcement follows receipt of all...

Endologix provides physicians with updated AFX information

Endologix has issued a letter to physicians with updated information about the AFX endovascular abdominal aortic aneurysm system. The voluntary letter, issued after discussions with...

Humacyte commences US phase II arterial bypass clinical trial

Humacyte has announced the initiation of a US phase II arterial bypass clinical trial of Humacyl, an investigational human acellular vessel, to test its safety...

Avinger announces new FDA clearance for Lumivascular imaging console

Avinger has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Lightbox L250 imaging console. Avinger says that with this...

Tej Singh: Intraoperative arterial flow measuring

Speaking to Vascular News, Tej Singh, El Camino Hospital, Mountain View, USA, discusses the new vascular flow device from Medistim, explaining why there is...

Santi Trimatchi: The IRAD Registry

Santi Trimarchi, University of Milan, Policlinico San Donato IRCCS, Milan, Italy speaks to Vascular News at the 2016 VEITHsymposium about the latest data from the...

Lombard Medical and MicroPort announce strategic partnership and investment agreement

Lombard Medical and MicroPort Scientific Corporation have announced a strategic partnership and a significant infusion of capital into Lombard Medical by MicroPort. According to...

Stefan Müller-Hülsbeck: The current drug-eluting stent landscape

In this interview, Stefan Müller-Hülsbeck, Diako Hospital, Flensburg, Germany, explains the implications of fresh two-year drug-eluting stent data from the MAJESTIC trial, and discusses...

Bentley receives CE mark for new BeGraft aortic stent graft

In November 2016, Bentley launched its BeGraft aortic stent graft system: a balloon expandable, large diameter covered stent with sizes ranging from 12mm to...

Andrew Holden: Nellix EVAS Global Forward Registry

  Andrew Holden (Auckland City Hospital, Auckland, New Zealand) is one of the principal investigators of the Nellix EVAS FORWARD Global Registry. He explained to...

Matt Thompson: The Endologix portfolio within the physician’s armamentarium

Matt Thompson (Chief Medical Officer, Endologix) speaks to Vascular News about what plans he has in his new role and the place of the...

Bob Mitchell: Latest developments in Nellix EVAS

  Speaking to Vascular News at the 2016 VEITHsymposium, Bob Mitchell (President, Endologix) discusses updated Nellix instructions for use and the potential of the endovascular...

Study shows fewer aortic aneurysm repairs and higher death rate in...

A new study published in the New England Journal of Medicine has shown that surgeons in England operate significantly less often on aortic aneurysms...

PERICLES registry analysis produces new classification for chEVAR gutter-related endoleaks

“Systematic scrutiny” of the large patient cohort in the PERICLES registry has resulted in a new classification describing three distinct patterns of chimney endovascular...

biolitec introduces new Leonardo Mini multi-function laser

biolitec has announced the development of a “revolutionary, versatile and compact laser for medical application,” with the Leonardo Mini—“a space-saving, efficient, and versatile multi-functional...

Vascular News 72 – November 2016 US Edition

Highlights: -EVAR 1 trial 15-year follow-up published: Lifelong surveillance of EVAR and prompt reintervention are paramount -IVUS may be a more accurate method than...

Vascular News 72 – November 2016

Highlights: -EVAR 1 trial 15-year follow-up published: Lifelong surveillance of EVAR and prompt reintervention are paramount -IVUS may be a more accurate method than...

Assessing the outcomes of venous interventions

These are exciting times for physicians involved in the management of venous disease. There have been important advances in basic scientific research and crucial...

Valiant Captivia stent graft shows 90% freedom from dissection-related mortality at...

The Valiant Captivia thoracic stent graft system (Medtronic) has demonstrated freedom from all-cause mortality of 79.4% and freedom from dissection-related mortality of 90% at...

Venography and IVUS for the diagnosis and treatment of iliofemoral venous...

The results of the VIRTUS feasibility study—analysing the performance of the Vici venous stent system (Veniti) in achieving patency of venous lesions up to...

Significant cost savings and no major adverse events with the Fast-Track...

The LIFE registry demonstrated safe and effective patient outcomes when using a “Fast-Track” endovascular aortic repair (EVAR) protocol—percutaneous access, no general anaesthesia, no intensive...

TIGRIS trial finds no stent fractures and positive primary patency in...

Twenty-four month TIGRIS trial follow-up data show that treatment using the Tigris nitinol stent (Gore) for long lesions in the superficial femoral and popliteal...

Device developments in EVAR: What we learned from the past; what...

The introduction of endovascular grafts for treatment of abdominal aortic aneurysms represents the major determinant for the endovascular revolution of the last 25 years....

Merit Medical receives 510(k) clearance for the SwiftNINJA steerable microcatheter

Merit Medical Systems has received 510(k) clearance for the SwiftNINJA steerable microcatheter, covering peripheral and coronary applications. With the exception of Japan, Merit has...

New medical director named to SVS Patient Safety Organization

Jens Eldrup-Jorgensen has been named the new medical director of the Society for Vascular Surgery Patient Safety Organization (SVS PSO). He will replace Jack...

Current status on drug-eluting devices in dialysis access

Dialysis access fistulae and grafts are life-saving in patients with renal insufficiency and failure. Numbers of patients requiring haemodialysis have continued to rise over...

The Vascular Society celebrates its golden anniversary

The Vascular Society of Great Britain and Ireland celebrates its golden anniversary in Manchester later this month. It was initially founded by Sol Cohen...

Cleveland Clinic Vascular Industry Externship providing real-world operating room insight for...

A novel one-week externship programme for members of the vascular surgery industry has been launched at Cleveland Clinic, Cleveland, USA; the busiest vascular unit...

Quick-fire Dreiländertagung

From 4–8 October, the Dreiländertagung meeting was held at the Kursaal centre in Bern, Switzerland. Taking place every three years, the German-speaking meeting brings...

IVUS may be a more accurate method than venography for assessing...

Fresh data from the VIRTUS feasibility study presented at the Vascular Interventional Advances (VIVA) annual conference 2016 (18–22 September, Las Vegas, USA) suggest that...

Vincent Riambau

The first to do so in his family, Vincent Riambau always felt a pull to become a surgeon. Attending procedures whenever he could, he...

Mortality rates of ruptured abdominal aortic aneurysm repair have not changed...

Ruptured abdominal aortic aneurysms (rAAA) are associated with an overall mortality rate of over 80%, and, according to the US Centers for Disease Control...

Stellarex ILLUMENATE 12-month pivotal results are “top-tier” in complex patients

Spectranetics has announced that the final 12-month results of the Stellarex drug-coated balloon ILLUMENATE pivotal trial have been presented at the Transcatheter Cardiovascular Therapeutics...

Spectranetics files FDA pre-market approval application for the Stellarex drug-coated balloon

Spectranetics has submitted its pre-market approval application for the Stellarex drug-coated angioplasty balloon to the US Food and Drug Administration (FDA). Stellarex is designed to restore...

Shockwave Medical announces plans for “largest ever” calcified peripheral artery disease...

Shockwave Medical has announced plans for DISRUPT PAD III—what is claims is the “largest ever” multicentre randomised study to exclusively enrol patients with calcified...

Initial patients enrolled in first-in-man study of Selution sirolimus-coated balloon

Med Alliance has announced first patient enrolment in the first-in-man study of the Selution novel sirolimus-coated balloon. Patients were enrolled at the Universitaets-Herzzentrum, Bad...

FDA approves TOBA II BTK pivotal IDE clinical study

The US Food and Drug Administration (FDA) has granted staged approval for Intact Vascular’s investigational device exemption (IDE) application to begin its TOBA II BTK...

Avinger launches upgraded Lightbox imaging console

Avinger has announced the US launch of an enhanced version of the company’s Lightbox imaging console. The Lightbox provides a dual display of images...

VasQ series at Berlin’s Charité University Hospital produces “exceptionally promising results”

As part of the main scientific programme at Dreiländertagung 2016 (4–8 October, Bern Switzerland), Peter Olschewski has reported “exceptionally promising results” from the first...

NEAT trial shows six times fewer post-creation interventions with endovascular than...

NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...

Teleflex receives FDA clearance for Arrow JACC with Chlorag+ard technology and...

Teleflex has received US Food and Drug Administration 510(k) clearance to market its Arrow JACC with Chlorag+ard technology and TightTrack tunneler. Arrow JACC with Chlorag+ard technology is...

Brilinta fails to demonstrate benefit over clopidogrel for peripheral artery disease...

AstraZeneca has announced that top-line results from the EUCLID trial indicate that Brilinta (ticagrelor) did not demonstrate a benefit over clopidogrel in a symptomatic...

Covered bridging stents in endovascular aneurysm repair

Over the past two decades, endovascular repair of abdominal aortic aneurysms (EVAR) has gained popularity. However, specified anatomic characteristics are required to achieve durable...

The use of robotics in peripheral artery disease interventions

Despite significant advances in pharmacotherapy and device technology for percutaneous cardiovascular interventions, the fundamental technique of manually advancing intravascular devices at the patient’s table...

Treatment of superficial vein thrombosis with intermediate doses of tinzaparin

Superficial vein thrombosis (SVT) is a common disease affecting 3–11% of the general population, while in patients with varicose veins the incidence of SVT...

Lymphoedema management: A collaborative approach for patients and clinicians

Lymphoedema is a chronic, progressive condition which can often be debilitating. It is caused by a deficiency or failure of the lymphatic system. Due...

Endothermal heat-induced thrombosis after endovenous laser ablation—a rare complication with safe...

Ovsep Mandzhikian, Moscow, Russia, reports on his centre’s recent experience of endothermal heat-induced thrombosis following treatment with endovenous laser and radial fibres, suggesting that...

New developments in dialysis grafts

With the rising incidence of haemodialysis worldwide, there is an ever-increasing need for creative, durable means of access. The National Kidney Foundation and Centers...

Acute and chronic paediatric limb ischaemia

Nothing is more frightening than an injured child. In general, paediatric limb ischaemia is a traumatic event presenting with varying degrees of severity. Paediatric...

Ra Medical Systems receives European approval for DABRA atherectomy and Pharos...

Ra Medical Systems has received CE mark approval for both the DABRA atherectomy system with catheter and the Pharos excimer laser to treat psoriasis,...

New SVS peripheral artery disease reporting standards announced

The Society for Vascular Surgery has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease. Recommended reporting standards...

Medtronic receives FDA clearance of TrailBlazer angled peripheral support catheter

The US Food and Drug Administration (FDA) has cleared Medtronic’s TrailBlazer angled support catheter for use in the peripheral vascular system. The TrailBlazer angled support...

New technology add-on payment awarded for Gore Excluder iliac branch endoprosthesis

The US Centers for Medicare and Medicaid Services (CMS) has granted the Gore Excluder iliac branch endoprosthesis (IBE) new technology status. Beginning on 1...

Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) in the treatment of femoropopliteal artery...

Lutonix Global Real-World Registry 24-month outcomes presented at VIVA 2016

Bard has announced the presentation of the final 24-month results from the Lutonix Global Real-World Registry at the Vascular Intervention Advances (VIVA) 2016 meeting...

Positive late-breaking DANCE clinical trial data presented at VIVA 2016

Christopher Owens, associate professor of Surgery in the Division of Vascular and Endovascular Surgery at the University of California, San Francisco (UCSF), USA, has...

Zilver PTX with thumbwheel delivery system launched in France

Cook Medical has launched the Zilver PTX drug-eluting peripheral stent thumbwheel delivery system in France, with the French Health Ministry now having approved reimbursement...

Medtronic Valiant Captivia demonstrates safety and efficacy at three years

Medtronic has announced new data, demonstrating safety and efficacy at three years in acute complicated type B aortic dissection patients treated with the Valiant Captivia thoracic...

One-year Japanese results support use of the Viabahn endoprosthesis to treat...

Gore has announced positive results from a prospective, multicentre investigational device exemption (IDE) clinical study of the Viabahn endoprosthesis with heparin bioactive surface in...

Endologix reports positive clinical data from Ovation LIFE study

Endologix has announced positive clinical data from the Ovation LIFE (Least Invasive Fast-Track EVAR) study. Zvonimir Krajcer, co-director, Peripheral Vascular Disease Service at Texas...

First implant completed in pivotal study of Gore TAG thoracic branch...

The first implant of Gore’s TAG thoracic branch endoprosthesis has been completed as part of the device’s pivotal study. The patient was enrolled by...

FDA approves six-month primary endpoint for the Lutonix below-the-knee drug-coated balloon

The US Food and Drug Administration (FDA) has approved an Investigational Device Exemption (IDE) supplemental application to modify the primary endpoint to a six-month...

QT Vascular announces FDA approval to initiate pivotal trial of Chocolate...

The US Food and Drug Administration (FDA) has granted QT Vascular conditional Investigational Device Exemption (IDE) approval, allowing the company to begin enrolling patients...

Positive results for Passeo-18 drug-coated balloon and Pulsar-18 bare metal stent...

Biotronik has showcased the efficacy of its lower limb intervention portfolio at a scientific symposium at CIRSE 2016 (10–14 September, Barcelona, Spain). Encouraging data...

Vivasure Medical announces €16.2m in financing to advance commercialisation of closure...

Vivasure Medical has completed a Series C financing of €16.2m (US$18.3m). The round was led by Life Sciences Partners (The Netherlands), investing from its...

Veniti closes on US$25m from Boston Scientific

Veniti has closed on US$25m in Series D equity financing from Boston Scientific Corporation. The funds will allow Veniti to complete the VIRTUS trial...

Ultrasound-enhanced catheter-directed thrombolysis as the standard of care for acute DVT

Ash Verma, Clearwater, USA, writes how last year, he happened upon a routine case that struck him as both totally unremarkable and absolutely extraordinary....

Dittmar Bӧckler

A budding pilot, Dittmar Böckler’s flight plan was altered by the onset of a sudden illness as a teenager. The experience introduced him to...

In the spotlight: Occupational radiation

In this special feature, Vascular News takes a look at occupational radiation—one of the most pressing concerns for vascular and endovascular professionals—speaking to several experts about the...

Absorb bioresorbable scaffold yields 96% primary patency and freedom from reintervention...

Twelve-month follow-up of the everolimus-eluting, Absorb bioresorbable vascular scaffold (Abbott Vascular) below the knee has demonstrated “excellent safety, patency, and freedom from target lesion...

Iliac branch device results show value of internal iliac artery revascularisation

The new Excluder iliac branch endoprosthesis (Gore) is safe and effective at treating aortoiliac aneurysms and common iliac artery aneurysms, maintaining blood flow into...

Toshiba Medical Systems launches direct Northern Irish operations Ireland with the...

Toshiba Medical Systems has announced the acquisition of Belfast-based Medical Imaging NI Limited. Medical Imaging NI has been a Toshiba Medical Systems partner for...

Vascular News 71 – September 2016 US Edition

Highlights: -Iliac branch device results show value of internal iliac artery revascularisation -Absorb bioresorbable scaffold yields 96% primary patency and freedom from reintervention below...

Vascular News 71 – September 2016

Highlights: -Iliac branch device results show value of internal iliac artery revascularisation -Absorb bioresorbable scaffold yields 96% primary patency and freedom from reintervention below...

Gore Viabahn endoprosthesis celebrates 20 years since introduction

Gore is celebrating the 20th anniversary of the introduction of the Viabahn endoprosthesis; its stent graft for the treatment of complex peripheral vascular disease....

Any instructions for use non-adherence predicts graft-related adverse events in elective...

Frequently, instructions for use (IFU) parameters published by device manufacturers are not adhered to in order to increase patient candidacy for endovascular aneurysm repair...

CardioVascular Coalition urges increased awareness of peripheral artery disease in September

The CardioVascular Coalition (CVC)—a group of community-based cardiovascular and endovascular care providers, physicians, and manufacturers created to advance community-based solutions designed to improve awareness,...

EUCLID trial to analyse monotherapy of ticagrelor versus clopidogrel in patients...

Despite “overwhelming data” demonstrating the efficacy of antiplatelet therapy in heart disease and stroke, data for antiplatelet therapy for peripheral arterial disease (PAD) are...

Total endovascular repair of zone 2 aortic arch aneurysms can be...

One-year outcomes of a prospective, non-randomised, feasibility trial evaluating the treatment of aneurysms involving the proximal descending thoracic aorta indicate that total repair can...

Zenith endograft produces durable repair while long-term survival rates “remain poor”

Endovascular aneurysm repair (EVAR) using the Zenith endograft (Cook Medical) represents durable repair with a low risk of abdominal aortic aneurysm-related death at 14...

Predicting type B aortic dissection outcomes when the patient arrives

Stanford type B aortic dissection carries a better prognosis compared with type A dissection and 90% of patients survive to hospital discharge. The management...

Bluegrass Vascular announces CE mark approval and successful commercial use of...

Bluegrass Vascular Technologies has received CE mark approval and is launching limited commercial sale of its Surfacer Inside-Out access catheter system. The Surfacer system...

Gore DrySeal Flex introducer sheath now commercially available

Gore has announced the commercial availability of the Gore DrySeal Flex introducer sheath, after recently gaining clearance for use by regulatory bodies in the...

Solutions for aortic disease: Consider the whole picture

Founded in 2000, JOTEC develops, manufactures and markets medical devices for aortic and peripheral vascular disease. This Educational Supplement looks at Jotec's broad product portfolio...

Cardiovascular Systems releases 30-day results from LIBERTY 360° study

Cardiovascular Systems has released procedural and 30-day results from its LIBERTY 360° study in a late-breaking presentation at the 2016 Amputation Prevention Symposium (AMP;...

Cook Medical issues global recall of Roadrunner UniGlide hydrophilic wire guides...

The US Food and Drug Administration has announced that Dutch company DSM Biomedical BV—Cook Medical’s supplier of hydrophilic coating for the Roadrunner Uniglide hydrophilic...

First patients treated with Endologix’s Ovation Alto abdominal stent graft system

The first two patients with abdominal aortic aneurysms (AAA) have been treated with Endologix’s Ovation Alto abdominal stent graft system. The patients were treated...

TOBA study results demonstrate 76.4% 12-month primary patency and 89.5% freedom...

The one-year results from Intact Vascular’s Tack Optimized Balloon Angioplasty (TOBA) clinical study have been published in the Journal of Vascular Surgery. The TOBA study...

US branch/fenestrated EVAR use soars by over 500% in a decade

New US research indicates that there was a widespread and steady decline in elective open abdominal aortic aneurysm repairs for Medicare patients from 2003...

WAVES trial shows 100% vein closure at one month with short...

A post-market evaluation of the VenaSeal closure system (Medtronic) has found that, at one month, 100% of treated veins remained closed, quality of life...

First randomised Stellarex DCB data show 12-month outcomes superior to percutaneous...

Marianne Brodmann of Medical University Graz, Austria, has presented the final 12-month results of the Stellarex (Spectranetics) ILLUMENATE drug-coated balloon European randomised clinical trial...

Occupational radiation exposure: How much should I worry?

Christopher G Carsten III, Greenville Health System, Greenville, SC, USA Radiation safety practices have made tremendous advances since the discovery of Roentgen’s X-rays over 120...

Improved renal function after renal artery stenting is associated with improved...

Further sub-group analysis of CORAL trial data indicates that retrieval of renal function after renal artery stenting improves survival and decreases cardiovascular and renal...

Complex triple or quadruple FEVAR does not increase perioperative mortality or...

At the Vascular Annual Meeting (9–11 June, National Harbor, USA), data were presented suggesting that complex triple or quadruple fenestrated endovascular aneurysm repair (FEVAR)...

Essential Medical receives FDA approval for X-Seal 6F vascular closure device...

Essential Medical has received investigational device exemption (IDE) approval from the US Food and Drug Administration (FDA) to begin the US clinical trial of...

Promising findings for novel drug-eluting peripheral stent

A new animal study, presented at EuroPCR (17–20 May, Paris), indicates that a novel, fluoropolymer-coated, self-expanding, paclitaxel-eluting peripheral stent (Eluvia, Boston Scientific) is associated...

Vasorum receives premarket FDA approval for Celt ACD vascular closure device

Vasorum has received approval of its premarket approval application from the US Food and Drug Administration (FDA). Celt ACD, which has received CE mark and...

AV Medical announces initial Chameleon PTA balloon catheter US experience

AV Medical has commenced cases in the USA with its Chameleon angioplasty balloon catheter. With its Supervision design, an AV Medical press release says...

Cydar EV gains FDA clearance for 3D surgical guidance software

The US Food and Drug and Administration (FDA) has granted 510(k) clearance for the UK-based start-up Cydar's EV surgical guidance software, used in X-ray guided vascular...

Contego Medical completes enrolment of Paladin clinical registry

Contego Medical has completed enrolment in the Paladin Carotid Post­-dilation Balloon System Registry in Europe. The registry involves 5 centres with 100 total patients,...

Early follow-up of FEVAR/BEVAR using supra-coeliac sealing zones and four-vessel designs...

Fenestrated and branched endovascular aneurysm repair (FEVAR/BEVAR) using supra-coeliac sealing zones and four-vessel designs is safe can be performed with “excellent” early outcomes according...

Initial STABLE II data favourable for treatment of chronic type B...

Initial results from the STABLE II study indicate that a covered stent graft with a bare metal stent is safe and effective in treating...

Nellix IDE trial shows low morbidity and mortality with high procedural...

Primary safety and efficacy endpoints for the Nellix system (Endologix) investigational device exemption (IDE) trial have been achieved at one year, with “very low...

NICE issues approval for endovenous mechanochemical ablation for varicose veins in...

The National Institute for Health and Care Excellence (NICE) has recently issued approval via Interventional Procedure Guidance IPG557 for endovenous mechanochemical ablation for the treatment of...

New report concludes endovascular procedures performed in office-based facilities result in...

The CardioVascular Coalition (CVC)—a group of community-based endovascular care providers, physicians, and manufacturers created to advance community-based solutions designed to improve awareness, prevention, and...

Medtronic receives FDA approval for IN.PACT Admiral DCB 150mm lengths

Medtronic has received US Food and Drug Administration (FDA) approval for the IN.PACT Admiral drug-coated balloon (DCB) in longer, 150mm lengths. The 150mm length...

EVAS Sealing Technology: The new paradigm in AAA therapy (OUS only)

This supplement highlights how the power of choice is transforming AAA treatment in Europe. It also underscores the impact that EndoVascular Aneurysm Sealing (EVAS)...

Edward Diethrich warns NCVH delegates about the dangers of radiation

The delivery and exploration of new technology is required to reduce harmful levels of radiation during endovascular procedures, according to Edward Diethrich, a veteran...

Plain balloon angioplasty remains a useful adjunct to drug-coated balloons for...

Despite improved outcomes in recent drug-coated balloon trials, standard balloons still have an important and complementary role to play in treating superficial femoral artery...

Veniti announces 1,000th patient treated with Vici Venous Stent

Physicians have now treated over 1,000 patients with the Vici Venous Stent. The product received CE mark in October 2013 and was first implanted...

Angiosome concept in the treatment of critical limb ischaemia

The role of angiosome-targeted revascularisation has been under research in Helsinki University Hospital since 2010. The areas of interest have been the feasibility of...

Key clinical questions I would like to see answered in the...

Therapies in deep venous thrombosis (DVT) have been slow to advance over the past 50 years. Recently, growing awareness and improvements in tools and...

The changing epidemiology of abdominal aortic aneurysms in Europe

Throughout the 20th century the impact of abdominal aortic aneurysms increased with well documented escalations in its incidence and associated mortality. Contemporary evidence from...

Lombard Medical announces CE mark approval for IntelliFlex LP delivery system...

Lombard Medical has received CE mark approval for its IntelliFlex Low Profile (LP) delivery system for the Aorfix endovascular stent graft. This new system will...

Silk Road Medical announces updated Enroute clinical data

Six presentations on Silk Road Medical’s Enroute transcarotid neuroprotection and stent system were given at the Society for Vascular Surgery annual meeting (8–11 June,...

VentureMed announces FDA approval of Flex scoring catheter

VentureMed has announced receipt of US Food and Drug Administration (FDA) 510(k) clearance for the Flex scoring catheter, an endovascular device that precisely and...

Endologix reports positive Nellix EVAS data from Italian multicentre study

Endologix has announced positive clinical data from the Italian Research Nellix Endoprosthesis (IRENE) study at the 2016 Society of Vascular Surgery (SVS) annual meeting...

TAG TEVAR family reaches 100,000 device distribution milestone

Gore has announced that its TAG thoracic device family has exceeded 100,000 devices distributed worldwide. The conformable TAG device is indicated in most geographical regions...

First Medtronic Valiant Evo thoracic stent graft system procedure completed in...

Medtronic and the University of Texas Health Science Center at Houston (UTHealth) have announced the first patient enrolled in a clinical study assessing the...

Australian Therapeutic Goods Administration approves Aorfix for the treatment of abdominal...

The Australian Therapeutic Goods Administration (TGA) has approved Lombard Medical’s Aorfix endovascular stent graft for inclusion on the Australian Register of Therapeutic Goods. The TGA has...

Final subject enrolled in Excluder thoracoabdominal branch endoprosthesis early feasibility study

Enrolment into Gore’s early feasibility study evaluating the Excluder thoracoabdominal branch endoprosthesis (TAMBE) for the treatment of aortic aneurysms involving the visceral branch vessels...

Developing a 48-hour mortality risk score for ruptured abdominal aortic aneurysm

A recent comparison of in-hospital mortality following rupture of an abdominal aortic aneurysm in England and the USA suggests that too few patients in...

False lumen embolisation for dissection

As our understanding of dissection grows, the fate of the false lumen through the progression of disease is becoming a more important variable that...

Wesley Moore

As a childhood asthmatic, Wesley Moore’s early exposure to the medical world saw physicians become his role models. By adolescence he was committed to...

Vascular News 70 – June 2016 US Edition

Highlights: -CX acknowledges “huge debt” owed to endovascular pioneers affected by radiation -Audience voting finds a place for false lumen embolisation in chronic type B...

Vascular News 70 – June 2016

Highlights: -CX acknowledges “huge debt” owed to endovascular pioneers affected by radiation -Audience voting finds a place for false lumen embolisation in chronic type B...

Ian Loftus reviews highlights of the CX 2016 Abstract Presentations

Ian Loftus, Co-chairman CX Abstract Board, reviews the highlights of this year’s CX Abstract Presentations session. He emphasises the quality of the work submitted...

Lombard Medical releases early results from the Altura endograft system clinical...

Lombard Medical, has announced the 30-day clinical results from 57 patients that were implanted with the Altura endograft system. The 57 patients were implanted...

Endologix completes patient enrolment in the Ovation LIFE study

Endologix has completed patient enrolment in the LIFE (Least invasive fast-track EVAR) study, a multicentre post-market registry designed to evaluate the Ovation abdominal stent...

Positive 12-month TOBA-BTK results presented at SCAI 2016

Positive twelve-month results from Intact Vascular’s Tack optimised balloon angioplasty—below-the-knee (TOBA-BTK) clinical study have been presented at the SCAI 2016 conference (4–7 May, Orlando,...

VenaSeal closure system demonstrates long-term durability and improved quality of life...

At the 2016 Charing Cross Symposium (26–29 April, London, UK) and the International Vein Congress (28–30 April, Miami, USA) Medtronic unveiled clinical data for...

Jetstream atherectomy system granted new CE mark for in-stent restenosis

Boston Scientific’s Jetstream atherectomy system has received CE mark for a new in-stent restenosis indication. This indication gives EU physicians “another safe and effective...

Essential Medical announces CE mark submission for MANTA large bore vascular...

Essential Medical has submitted its CE mark application for MANTA, the company's large bore vascular closure device.   The company says that its single-arm, 50-patient...

FDA approves Gadavist (gadobutrol) injection as first contrast agent for use...

The US Food and Drug Administration (FDA) has approved Bayer’s Gadavist (gadobutrol) injection for use with magnetic resonance angiography (MRA) to evaluate known or suspected...

CX audience voting finds a place for false lumen embolisation in...

At one of the 2016 Charing Cross (CX 2016; 26–29 April, London, UK) Great Debates, a small majority of the audience (53%) voted against...

CX acknowledges “huge debt” owed to endovascular pioneers affected by radiation

Since its introduction in the late 80s, endovascular therapy has become increasingly widespread and important. A mini-symposium held at the 2016 Charing Cross Symposium...

Abbott to acquire St Jude Medical

Abbott and St Jude Medical have announced today a definitive agreement for Abbott to acquire St Jude Medical. Under the agreement, St Jude Medical shareholders...

Individual Patient Data meta-analysis and EVAR 1 trial results presented at...

The teams of researchers and principal investigators who collected and analysed the data for the Individual Patient Data meta-analysis and EVAR 1 trial presented...

Shockwave Medical announces positive study results of Lithoplasty system for peripheral...

Shockwave Medical has announced positive clinical results from the pooled DISRUPT PAD Study, a single-arm, two-phase multicentre study evaluating the safety and performance of...

Gore Joins vascular and endovascular community in honouring 2016 Pioneers in...

Gore has joined with leaders across the vascular and endovascular community in honouring four European physicians as Pioneers in Performance at the 2016 Charing Cross...

Positive Nellix Global Registry and treatment of iliac aneurysm data presented...

Endologix has announced the presentation of positive clinical data for the Nellix EndoVascular Aneurysm Sealing (EVAS) system at the 38th Annual Charing Cross Symposium...

Presentation compares ENGAGE Global Registry with landmark EVAR 1 trial results

A presentation at the Abdominal Aortic Aneurysm Challenges session during the 2016 Charing Cross Symposium (26–29 April, London, UK) has compared the ENGAGE global registry...

“IVUS should be the gold standard for diagnosing and directing treatment...

In a study comparing multiplanar venography to intravascular ultrasound (IVUS) for diagnosing common or external iliac and common femoral vein stenosis, IVUS imaging was...

Early data from venous stent trials “very promising”

Two 2016 Charing Cross Symposium (CX 2016; 26–29 April, London, UK) presentations in the Venous Challenges Main Programme session have demonstrated the value of...

Good day for drug-coated balloons, swirling flow stents and drug-eluting stents...

The CX Peripheral Arterial Challenges session at the 2016 Charing Cross Symposium (CX 2016; 25–29 April, London, UK) saw a host of new developments...

Non-thrombotic iliac vein lesions trigger “paradigm shift”

Now that non-thrombotic iliac vein lesions (NIVLs) are more frequently recognised on modern imaging modalities, they are beginning to trigger a paradigm shift in...

New IN.PACT Admiral data reinforce efficacy in females, chronic total occlusions...

Medtronic has announced with several new presentations that showed durable and consistent clinical outcomes in the most challenging patients with peripheral artery disease. The...

QT Vascular submits request for IDE permission to begin US pivotal...

QT Vascular has submitted an investigational device exemption (IDE) for permission to begin the pivotal study of the Chocolate Touch drug-coated balloon in the...

AV Medical announces completes of 30-patient study with Chameleon balloon catheter

AV Medical Technologies has announced the culmination of a 30-patient study that evaluated the proprietary design of the Chameleon angioplasty balloon catheter. The study...

VENITI completes first use of VICI VERTO VENOUS STENT system

The first patient suffering from post-thrombotic syndrome associated with venous outflow obstruction has been treated with the VICI VERTO VENOUS STENT system. This stent...

Gore Excluder iliac branch endoprosthesis gains Health Canada approval

Health Canada has approved the Gore Excluder iliac branch endoprosthesis, making it the most recent off-the-shelf aortic branch device approved in Canada for the...

Auris Surgical Robotics to acquire Hansen Medical

Auris Surgical Robotics and Hansen Medical have signed a definitive merger agreement under which Auris will acquire Hansen Medical for US$4 per share in...

Feasibility study shows favourable results for atherectomy device in treating femoropopliteal...

A feasibility study of the JetStream XC atherectomy device (Boston Scientific) has shown high rates of procedural success, no device-stent interaction, and favourably low...

Delivering on patient-focused innovation

Lombard Medical’s portfolio, combining the revolutionary Altura Endograft System to treat standard abdominal aortic aneurysm patients and a new delivery system for Aorfix, the...

Vascular News Charing Cross Edition 2016 – US Edition

Highlights: -Tackling the challenges in the vascular and endovascular arena -CX Venous Workshop -CX Vascular Access course -CX Edited Live Cases -CX ilegx Collaboration...

Vascular News Charing Cross Edition 2016

Highlights: -Tackling the challenges in the vascular and endovascular arena -CX Venous Workshop -CX Vascular Access course -CX Edited Live Cases -CX ilegx Collaboration...

Vascular News 69 – January 2016 US Edition

Highlights: -Neuromonitoring changes trigger protocol against spinal cord ischaemia during TEVAR -New European industry code: Sponsorship of physicians to attend congresses to be done...

Vascular News 69 – January 2016

Highlights: -Neuromonitoring changes trigger protocol against spinal cord ischaemia during TEVAR -New European industry code: Sponsorship of physicians to attend congresses to be done...

In the spotlight: Atherectomy

The removal of plaque from peripheral arterial lesions is often needed when preparing vessels for adjunct therapies such as drug-coated balloons and drug-eluting stents....

One-day surgery for endovascular repair is a “growing trend” in the...

One-day surgery for endovascular repair, made possible by good patient selection and planning, is “safe and cost-effective” according to a talk given by Peter...

Endovascular revolution in the aorta: 25 years of a landmark case

On 7 September 1990, a 70-year-old man with severe chronic obstructive pulmonary disease and severe back pain caused by a 6cm abdominal aortic aneurysm...

Vascular News 68 – November 2015 – US Edition

Highlights: -IN.PACT SFA two-year results "have potential to drive paradigm shift" in femoropopliteal lesion treatment -PERICLES study helps bring chimney technique "out of the...

Vascular News 68 – November 2015

Highlights: -IN.PACT SFA two-year results "have potential to drive paradigm shift" in femoropopliteal lesion treatment -PERICLES study helps bring chimney technique "out of the...

IN.PACT SFA two-year results “have potential to drive paradigm shift” in...

Two-year results of the IN.PACT SFA randomised controlled trial demonstrate durability and continued superiority of the IN.PACT Admiral drug-coated balloon (Medtronic) over plain balloon...

Vascular News 67 – September 2015 – US Edition

Highlights: -"Working with radiation is like keeping a pet tiger in your living room" -Wearable exercise tracker improves intermittent claudication symptoms at six months...

Vascular News 67 – September 2015

Highlights: -"Working with radiation is like keeping a pet tiger in your living room" -Wearable exercise tracker improves intermittent claudication symptoms at six months...

Advancing EVAS towards standard of care for AAA repair (OUS only)

In this educational supplement, vascular specialists discuss how the Nellix EndoVascular Aneurysm Sealing (EVAS) system can address the challenge posed by type II endoleaks...

Vascular News Issue 66 – June 2015 – US Edition

Highlights: -One-year IMPROVE data suggest benefit of EVAR in ruptured aneurysms -New Eluvia drug-eluting stent shows 94.4% primary patency rate at nine months -Michael...

Vascular News Issue 66 – June 2015

Highlights: -One-year IMPROVE data suggest benefit of EVAR in ruptured aneurysms -New Eluvia drug-eluting stent shows 94.4% primary patency rate at nine months -Michael...

Vascular News Charing Cross Edition 2015 – US Edition

Highlights: -Discussion of controversies tops Charing Cross 2015 agenda -CX Venous Workshop -CX Live Peripheral Arterial Cases -CX Edited Live Cases -CX ilegx Collaboration...

SUPERA: Mimetic stent technology for simple and complex femoropopliteal lesions

The Supera Peripheral Stent System, from Abbott Vascular, is a unique vascular mimetic device that consists of six pairs of interwoven nitinol wires and...

Vascular News Charing Cross Edition 2015

Highlights: -Discussion of controversies tops Charing Cross 2015 agenda -CX Venous Workshop -CX Live Peripheral Arterial Cases -CX Edited Live Cases -CX ilegx Collaboration...

Vascular News Issue 65 – January 2015 – US Edition

Highlights: -Publishing individual outcome data way make physicians risk averse -Early results suggest Lithoplasty is effective in the treatment of calcified lesions -SPACE 2...

Vascular News Issue 65 – January 2015

Highlights: -Publishing individual outcome data way make physicians risk averse -Early results suggest Lithoplasty is effective in the treatment of calcified lesions -SPACE 2...

Vascular News Issue 64 – November 2014 – US Edition

Highlights: -C-arm angulation increases radiation exposure to operators during complex EVAR -EXCITE ISR results show superiority of laser atherectomy over angioplasty alone -Lutonix becomes...

Vascular News Issue 64 – November 2014

Highlights: -C-arm angulation increases radiation exposure to operators during complex EVAR -EXCITE ISR results show superiority of laser atherectomy over angioplasty alone -Lutonix becomes...

Hybrid OR: State-of-the-art imaging in a sterile environment – US Edition

The use of Hybrid OR—state-of-the-art imaging in an operative environment—is changing the way endovascular procedures are performed. Combined with a range of advanced tools...

Hybrid OR: State-of-the-art imaging in a sterile environment

The use of Hybrid OR—state-of-the-art imaging in an operative environment—is changing the way endovascular procedures are performed. Combined with a range of advanced tools...

Vascular News 63 – September 2014 – USA Edition

Highlights: -Two-stage TEVAR yields lower mortality and more protection against spinal cord injury -Endovascular repair of popliteal aneurysm maintains significant sac shrinkage at five...

Vascular News 63 – September 2014

Highlights: -Two-stage TEVAR yields lower mortality and more protection against spinal cord injury -Endovascular repair of popliteal aneurysm maintains significant sac shrinkage at five...

Vascular News 62 – June 2014 – USA Edition

Highlights: -CX 2014 audience recognises the impact of drug-eluting balloons -No type I or III endoleaks with the Incraft system for EVAR at two...

Vascular News 62 – June 2014

Highlights: -CX 2014 audience recognises the impact of drug-eluting balloons -No type I or III endoleaks with the Incraft system for EVAR at two...

EVAS: The game-changing solution for aortic aneurysms (OUS only)

The Nellix EndoVascular Aneurysm Sealing (EVAS) System from Endologix is designed to completely fill and seal the aneurysm, avoiding complications usually associated with traditional...

Advancing evidence-based medicine in the aorta

Vascular News interviewed international EVAR and TEVAR thought-leaders to gain their perspectives on evidence-based aortic intervention. The interviews show that long-term clinical evidence from...

Vascular News 61 – January 2014 – USA Edition

Highlights: -No difference between endovascular and open repair for ruptured aneurysms -Renal artery stenting no better than medical therapy alone in CORAL -Hybrid techniques...

Vascular News 61 – January 2014

Highlights: -No difference between endovascular and open repair for ruptured aneurysms -Renal artery stenting no better than medical therapy alone in CORAL-Hybrid techniques for...

Vascular News 60 – November 2013 USA Edition

Highlights: -Vascular surgery societies refuse to endorse TASC III -ESVS announces bankruptcy of annual meeting organiser -3D contrast-enhanced ultrasound potentially better at detecting endoleaks -Profile: Lowell Kabnick http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/60-Vascular-News_US.pdf

Vascular News 60 – November 2013

Highlights: -Vascular surgery societies refuse to endorse TASC III -ESVS announces bankruptcy of annual meeting organiser -3D contrast-enhanced ultrasound potentially better at detecting endoleaks -Profile: Lowell Kabnick     http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/60-Vascular-News_low-res.pdf

Vascular News 59 – September 2013 USA Edition

Highlights: -Inadequate sealing is top reason for endograft explant -"Aortic debranching safe and durable up to five years" -A unified voice for vascular surgery...

Vascular News 59 – September 2013

Highlights: -Inadequate sealing is top reason for endograft explant -"Aortic debranching safe and durable up to five years" -A unified voice for vascular surgery in...

Vascular News 58 – May 2013 USA Edition

Highlights: - Management of type II endoleak divides the experts at CX35 - Intermittent claudication: Lack of funding for supervised exercise programmes remains a global problem -...

Vascular News 58 – May 2013

Highlights: - Management of type II endoleak divides the experts at CX35 - Intermittent claudication: Lack of funding for supervised exercise programmes remains a global problem -...

Vascular News Issue 57 – January 2013 USA Edition

Highlights:-Initial experience of total endovascular arch aneurysm exclusion is "encouraging"-Stroke associated with a threefold increased future mortality in CREST-Advances in drug therapy for the...

Vascular News Issue 57 – January 2013

Highlights: -Initial experience of total endovascular arch aneurysm exclusion is "encouraging" -Stroke associated with a threefold increased future mortality in CREST -Advances in drug...

Vascular News Issue 56 – November 2012 USA Edition

Highlights: -Early follow-up shows promising results with bioabsorbable stent in the superficial femoral artery -Is the Cotavance withdrawal in the USA a setback for...

Vascular News Issue 56 – November 2012

Highlights: -Early follow-up shows promising results with bioabsorbable stent in the superficial femoral artery -Is the Cotavance withdrawal in the USA a setback for...

Vascular News Issue 55 – September 2012

Highlights: -Intensive endovascular simulation training improves performance -Stem cell mobilisation shows trend in improving amputation rate in critical limb ischaemia -Chimney and periscope grafts...

Vascular News Issue 54 – June 2012

Highlights: -Is the task for TASC III consensus too great? -World's first experience with a bioabsorbable stent for the superficial femoral artery presented at...

Vascular News Issue 53 – January 2012

Highlights: -Are "off-the-shelf" fenestrated endografts seeing a new dawn? -Lower restenosis and re-occlusion rates with drug-eluting balloons compared to angioplasty in DEBATE-BTK -Dismantling the...

Vascular News Issue 52 – November 2011

Highlights: -First-in-man experience heralds the era of bioabsorbable stents -Initial experience of total endovascular arch repair reported -Will long-term trial results boost endovascular treatment...

Vascular News Issue 51 – September 2011

Highlights: -Physician-modified endografts provide alternative for inoperable juxtarenal aneurysms -Vascular surgeons achieve best reported outcomes after carotid endarterectomy in CREST -SVS presents Lifetime Achievement...

Vascular News Issue 50 – June 2011

Highlights: -Are the EVAR boundaries being possibly pushed too far? -TASC guidelines set to recommend "endovascular first" for all lessions -64% of CX delegates...

Vascular News 49 – Jan 2011

Highlights: -Setback for gene therapy in TAMARIS -New EVAR devices presented at the VEITHsymposium -Is there a common theme for endovenous thermal ablation failure?...

Vascular News 48 – Nov 2010

Highlights: - One-year results show DESTINY of drug elution below the knee - ACE trialists conclude that EVAR offer no benefit over open repair...

Vascular News 47 – August 2010

Highlights: - Europe set for wave of next generation EVAR devices - Abbott Vascular seeks to expand carotid stenting indications after CREST trial -...

Vascular News 46 – May 2010

Highlights: -Landmark EVAR trials deliver new messages at Charing Cross -Future of renal artery stenting in peril -Differeing views on CREST -CX Office Based...

Vascular News 45 – January 2010

Highlights: -Is the DESTINY of drug-eluting stents below the knee? -European renal artery stenting trials draw fire from New York -Veith reports EVAR is...

Vascular News 44 – November 2009

Highlights: -ASTRAL trial results show no benefit for renal artery stenting -Cutting balloon no better than angioplasty -Setback for drug elution in the periphery as...

Vascular News 43 – August 2009

Highlights: -ICSS concludes carotid surgery is safer than stenting -Re-intervention higher after endovascular repair -Practice makes perfect for lower limb intervention -Profile: Michael Jacobs   http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/43-Vascular-News_lowres.pdf

Vascular News 42 – May 2009

Highlights: -NICE UK concludes that EVAR is cost-effective -Endovascular aortic questions to be settled by individual patient data meta-analysis -Kabnick: Limitations of the RECOVERY...

Vascular News 41 – February 2009

Highlights: -MIMIC proves benefit of angioplasty for claudicants -DREAM results shake New York -Swiss show superior foot care -Profile: Michael Gough http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/41-Vascular-News_lowres.pdf

Vascular News 40 – November 2008

Highlights: -UK NICE recommendations positive for EVAR -BASIL trial bypass benefit debated -Final ACST results: Sustained for early surgery -Profile: Michael DeBakey 1908-2008 http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/40-Vascular-News_lowres.pdf

Vascular News 39 – September 2008

Highlights: -Carotid trials reappraised -First ruptured thoracic aneurysm trial supports TEVAR -Profile: George Hamilton   http://o6xux43a6gs4eidym2svvhon-wpengine.netdna-ssl.com/wp-content/uploads/sites/7/2016/02/39-Vascular-News_lowres.pdf